8SDF | pdb_00008sdf

Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.79 Å
  • R-Value Free: 
    0.218 (Depositor), 0.217 (DCC) 
  • R-Value Work: 
    0.185 (Depositor), 0.186 (DCC) 
  • R-Value Observed: 
    0.187 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8SDF

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift

Song, G.Yuan, M.Liu, H.Capozzola, T.Lin, R.N.Torres, J.L.He, W.T.Musharrafieh, R.Dueker, K.Zhou, P.Callaghan, S.Mishra, N.Yong, P.Anzanello, F.Avillion, G.Vo, A.L.Li, X.Zhang, Y.Makhdoomi, M.Feng, Z.Zhu, X.Peng, L.Nemazee, D.Safonova, Y.Briney, B.Ward, A.B.Burton, D.R.Wilson, I.A.Andrabi, R.

(2025) Cell Rep 44: 115948

Macromolecule Content 

  • Total Structure Weight: 143.81 kDa 
  • Atom Count: 10,506 
  • Modeled Residue Count: 1,261 
  • Deposited Residue Count: 1,302 
  • Unique protein chains: 3

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Spike protein S1A [auth Z],
D [auth A]
205Severe acute respiratory syndrome coronavirus 2Mutation(s): 0 
UniProt
Find proteins for P0DTC2 (Severe acute respiratory syndrome coronavirus 2)
Explore P0DTC2 
Go to UniProtKB:  P0DTC2
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP0DTC2
Glycosylation
Glycosylation Sites: 1Go to GlyGen: P0DTC2-1
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Neutralizing antibody CC25.4 heavy chainB [auth H],
E [auth B]
229Homo sapiensMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 3
MoleculeChains  Sequence LengthOrganismDetailsImage
Neutralizing antibody CC25.4 light chainC [auth L],
F [auth C]
217Homo sapiensMutation(s): 0 

Oligosaccharides

Help  
Entity ID: 4
MoleculeChains Length2D Diagram GlycosylationD Interactions
2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranoseG [auth D]3N-Glycosylation
Glycosylation Resources
GlyTouCan: G21290RB
GlyCosmos: G21290RB
GlyGen: G21290RB

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAG

Query on NAG



Download:Ideal Coordinates CCD File
M [auth A]2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
MPD

Query on MPD



Download:Ideal Coordinates CCD File
H [auth Z]
I [auth Z]
J [auth H]
K [auth L]
L
H [auth Z],
I [auth Z],
J [auth H],
K [auth L],
L,
N [auth A],
O [auth B],
P [auth C]
(4S)-2-METHYL-2,4-PENTANEDIOL
C6 H14 O2
SVTBMSDMJJWYQN-YFKPBYRVSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.79 Å
  • R-Value Free:  0.218 (Depositor), 0.217 (DCC) 
  • R-Value Work:  0.185 (Depositor), 0.186 (DCC) 
  • R-Value Observed: 0.187 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 58.204α = 90
b = 142.996β = 94.13
c = 82.928γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
XDSdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesR01AI170928
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesCHAVD UM1 AI44462
Bill & Melinda Gates FoundationUnited StatesINV-004923

Revision History  (Full details and data files)

  • Version 1.0: 2024-03-13
    Type: Initial release
  • Version 1.1: 2024-03-20
    Changes: Database references
  • Version 1.2: 2024-12-25
    Changes: Advisory, Derived calculations, Structure summary
  • Version 1.3: 2025-07-16
    Changes: Database references